In recent years, we have witnessed an alarming worldwide shortage of intravenous immunoglobulin, an agent that is commonly used to treat various autoimmune and systemic inflammatory diseases, many of which affect the nervous system. In this Viewpoint, Bayryet al.explain the reasons for this shortage, and propose some potential solutions to the problem.
- Jagadeesh Bayry
- Michel D Kazatchkine
- Srini V Kaveri
